LIPLASOME PHARMA ApS

CVR29428514

Core data

Name
LIPLASOME PHARMA ApS
Address
Tabletvej 1, 7100, Vejle
Founded
Feb 8, 2006
Employees (CVR)
0
Locations (P-units)
1View locations
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of LIPLASOME PHARMA ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account

Description

LiPlasome Pharma ApS har udviklet en ”drug delivery” teknologi som vha. liposomaleformuleringer af kendte anticancer stoffer sikrer en mere målrettet kræftbehandling. LiPlaCis, som er selskabets første produkt er eksklusivt licenseret til Chosa AB.

Financials

Company financials
Reporting period
2025DKK
Gross profit
-28,000
Profit before tax
62,000
Net income
62,000
Total assets
2,389,000
Equity
2,377,000
Avg. employees
0
2018–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
4928****Show full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Hans-Henrik Horsted EriksenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • ADM. DIR.
John Riis MortensenRoles
Board
TitlesFORMAND
Claus Bagger-SørensenRoles
Reelle ejere
TitlesReel ejer
Steen Bagger-SørensenRoles
Reelle ejere
TitlesReel ejer

Auditor

EY Godkendt RevisionspartnerselskabAuditorTom B. LassenRolestatsaut. revisorFromMar 29, 2026
AuditorTobias OppermannRolestatsaut. revisorFromMar 29, 2026
Ownership90–99.99 %Voting rights90 %FromOct 14, 2022

Beneficial owners

Ownership46.89 %Voting rights46.89 %FromDec 19, 2019
Ownership46.89 %Voting rights46.89 %FromDec 19, 2019

Ultimate owners

Claus Bagger-Sørensen
45–66.66 %
Steen Bagger-Sørensen
45–66.66 %

Official sources